<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477103405</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111547.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19961001xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF03048673</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF03048673</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Multimodal strategy in locally advanced inoperable head and neck cancer</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="b">A pilot study</subfield>
   <subfield code="c">[Narendra Deo, M. Gupta, B. Shrivastava, K. Agrawal]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Squamous cell carcinoma of the Head and Neck is the commonest cancer at our centre and the majority were in locally advanced inoperable stage (stage III and IV) where surgery and/or radiotherapy were able to cure less than 10% of the patients. This study was conducted to determine the role of neo-adjuvant chemotherapy in these cases and to bring locally advanced inoperable disease within perview of surgery and/ or curative radiotherapy. A total of 32 patients found inoperable or unsuitable for curative radiotherapy were treated with neoadjuvant chemotherapy (Cisplatinum, 5FU, Bleomycin and Hydroxyurea × 3 cycles) followed by surgery and or radiotherapy. All the patients were evaluable for response. An objective response rate following neoadjuvant chemotherapy was 81% (28% CR, 53% PR). Subsequent surgery or radiotherapy were able to have 56.25% (18/32) of patients disease free at 4 years with overall survival 46.8% at 4 years. Neoadjuvant chemotherapy along with radiotherapy and/or surgery might be an effective protocol in controlling advanced inoperable head and neck squamous cell carcinoma.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Association of Otolaryngologists of India, 1996</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Deo</subfield>
   <subfield code="D">Narendra</subfield>
   <subfield code="u">Surgical Oncology, Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Gupta</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Shrivastava</subfield>
   <subfield code="D">B.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Agrawal</subfield>
   <subfield code="D">K.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Indian Journal of Otolaryngology and Head and Neck Surgery</subfield>
   <subfield code="d">Springer India</subfield>
   <subfield code="g">48/4(1996-10-01), 327-330</subfield>
   <subfield code="x">0019-5421</subfield>
   <subfield code="q">48:4&lt;327</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">48</subfield>
   <subfield code="o">12070</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF03048673</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">brief-communication</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF03048673</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Deo</subfield>
   <subfield code="D">Narendra</subfield>
   <subfield code="u">Surgical Oncology, Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Gupta</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Shrivastava</subfield>
   <subfield code="D">B.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Agrawal</subfield>
   <subfield code="D">K.</subfield>
   <subfield code="u">Cancer Hospital &amp; Research Institute, Gwalior (M.P.), India</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Indian Journal of Otolaryngology and Head and Neck Surgery</subfield>
   <subfield code="d">Springer India</subfield>
   <subfield code="g">48/4(1996-10-01), 327-330</subfield>
   <subfield code="x">0019-5421</subfield>
   <subfield code="q">48:4&lt;327</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">48</subfield>
   <subfield code="o">12070</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
